<bill session="108" type="s" number="2328" updated="2023-01-15T04:48:55Z">
  <state datetime="2004-04-21">REFERRED</state>
  <status>
    <introduced datetime="2004-04-21"/>
  </status>
  <introduced datetime="2004-04-21"/>
  <titles>
    <title type="display">Pharmaceutical Market Access and Drug Safety Act of 2004</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.</title>
    <title type="short" as="introduced">Pharmaceutical Market Access and Drug Safety Act of 2004</title>
    <title type="popular">Imports of Prescription Drugs bill</title>
  </titles>
  <sponsor bioguide_id="D000432"/>
  <cosponsors>
    <cosponsor bioguide_id="B000711" joined="2004-04-27"/>
    <cosponsor bioguide_id="C001040" joined="2004-04-21"/>
    <cosponsor bioguide_id="C001041" joined="2004-06-14"/>
    <cosponsor bioguide_id="C000705" joined="2004-07-06"/>
    <cosponsor bioguide_id="D000064" joined="2004-04-21"/>
    <cosponsor bioguide_id="D000596" joined="2004-04-22"/>
    <cosponsor bioguide_id="D000388" joined="2004-09-10"/>
    <cosponsor bioguide_id="D000563" joined="2004-04-27"/>
    <cosponsor bioguide_id="E000286" joined="2004-06-24"/>
    <cosponsor bioguide_id="F000061" joined="2004-04-21"/>
    <cosponsor bioguide_id="F000062" joined="2004-04-22"/>
    <cosponsor bioguide_id="I000025" joined="2004-06-09"/>
    <cosponsor bioguide_id="J000072" joined="2004-06-22"/>
    <cosponsor bioguide_id="J000177" joined="2004-04-21"/>
    <cosponsor bioguide_id="K000105" joined="2004-04-21"/>
    <cosponsor bioguide_id="K000148" joined="2004-04-26"/>
    <cosponsor bioguide_id="K000305" joined="2004-05-06"/>
    <cosponsor bioguide_id="L000174" joined="2004-04-26"/>
    <cosponsor bioguide_id="L000261" joined="2004-05-04"/>
    <cosponsor bioguide_id="L000035" joined="2004-06-15"/>
    <cosponsor bioguide_id="L000447" joined="2004-04-21"/>
    <cosponsor bioguide_id="M000303" joined="2004-04-21"/>
    <cosponsor bioguide_id="M000702" joined="2004-04-29"/>
    <cosponsor bioguide_id="N000032" joined="2004-04-22"/>
    <cosponsor bioguide_id="P000590" joined="2004-04-21"/>
    <cosponsor bioguide_id="R000146" joined="2004-07-06"/>
    <cosponsor bioguide_id="S000064" joined="2004-07-06"/>
    <cosponsor bioguide_id="S000148" joined="2004-04-22"/>
    <cosponsor bioguide_id="S000663" joined="2004-04-21"/>
    <cosponsor bioguide_id="S000709" joined="2004-06-18"/>
    <cosponsor bioguide_id="S000770" joined="2004-04-21"/>
  </cosponsors>
  <actions>
    <action datetime="2004-04-21">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2004-04-21">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S4227-4228"/>
    </action>
    <action datetime="2004-04-21" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2004-05-20">
      <text>Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 108-470.</text>
    </action>
    <action datetime="2004-07-14">
      <text>Committee on the Judiciary. Hearings held.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Hearings"/>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Hearings, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative fees"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Australia"/>
    <term name="Business records"/>
    <term name="Canada"/>
    <term name="Civil actions and liability"/>
    <term name="Commerce"/>
    <term name="Consumer education"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Customs administration"/>
    <term name="Defective products"/>
    <term name="Department of Health and Human Services"/>
    <term name="Directories"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Economics and Public Finance"/>
    <term name="Electronic government information"/>
    <term name="English language"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Evidence (Law)"/>
    <term name="Export controls"/>
    <term name="Exports"/>
    <term name="Finance and Financial Sector"/>
    <term name="Fines (Penalties)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health care fraud"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Internet"/>
    <term name="Japan"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="New Zealand"/>
    <term name="Oceania"/>
    <term name="Packaging"/>
    <term name="Patent infringement"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Product counterfeiting"/>
    <term name="Restrictive trade practices"/>
    <term name="Science, Technology, Communications"/>
    <term name="Standards"/>
    <term name="State laws"/>
    <term name="Surety and fidelity"/>
    <term name="Switzerland"/>
    <term name="Translating and interpreting"/>
    <term name="Web sites"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary date="2004-08-06T20:41:24Z" status="Introduced in Senate">Pharmaceutical Market Access and Drug Safety Act of 2004 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions governing the importation of prescription drugs. Requires the Secretary of Health and Human Services to promulgate regulations allowing the importation of prescription drugs by registered exporters or registered importers from Canada within 90 days of passage of this Act and from Australia, European Union countries, Japan, New Zealand, or Switzerland within one year.

Provides for inspection, tracking of drugs, and registration and inspection fees for registered importers and exporters.

Requires manufacturers to: (1) submit a statement to the Secretary explaining each difference between a drug approved and distributed in the United States and a related drug distributed in a foreign country; and (2) submit an application to the Food and Drug Administration (FDA) for approval of a related drug that is distributed in a foreign country if there is no comparable drug already approved in at least half of the permitted countries that can be imported to the United States.

 Allows for the immediate importation of prescription drugs for personal use from licensed Canadian pharmacies.

Amends the Clayton Act to prohibit drug manufacturers from preventing importation by engaging in behavior such as charging higher prices or limiting supplies to registered exporters and importers or changing the form of the drug for such purpose.

States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.

Requires the Secretary of Homeland Security to refuse admission of drugs that violate importation provisions. Allows the destruction of certain violative shipments.

Amends the Controlled Substances Act to repeal the exemption that permitted individuals to import controlled substances for personal medical use.</summary>
</bill>
